Pages that link to "Clopidogrel"

The following pages link to Clopidogrel:

Displayed 50 items.

• Desirudin ‎ (← links)
• Chronic stable angina overview ‎ (← links)
• The Living Guidelines: STEMI Antiplatelet Agents / Anticoagulants Therapy: Clopidogrel Suggest Revisions to the CLASS IIa Guidelines ‎ (← links)
• The Living Guidelines: STEMI Antiplatelet Agents / Anticoagulants Therapy: Warfarin Suggest Revisions to the CLASS I Guidelines ‎ (← links)
• The Living Guidelines: STEMI Thienopyridines Suggest Revisions to the CLASS I Guidelines ‎ (← links)
• The Living Guidelines: STEMI Thienopyridines Suggest Revisions to the CLASS IIa Guidelines ‎ (← links)
• The Living Guidelines: Oral Antiplatelet Therapy View the Current CLASS IIb Guidelines ‎ (← links)
• The Living Guidelines: Oral Antiplatelet Therapy Suggest Revisions to the CLASS IIb Guidelines ‎ (← links)
• The Living Guidelines: Antiplatelet Agents/Anticoagulants: Clopidogrel View the Current CLASS I Guidelines ‎ (← links)
• The Living Guidelines: Antiplatelet Agents/Anticoagulants: Clopidogrel View the Current CLASS IIa Guidelines ‎ (← links)
• The Living Guidelines: Antiplatelet Agents/Anticoagulants: Clopidogrel Suggest Revisions to the CLASS IIa Guidelines ‎ (← links)
• The Living Guidelines: Chronic Stable Angina Pectoris Antiplatelets/Anticoagulants Therapy Suggest Revisions to the CLASS I Guidelines ‎ (← links)
• The Living Guidelines: UA/NSTEMI Recommendations for Additional Management Considerations for Antiplatelet and Anticoagulant Therapy Suggest Revisions to the CLASS I Guidelines ‎ (← links)
• The Living Guidelines: UA/NSTEMI Recommendations for Additional Management Considerations for Antiplatelet and Anticoagulant Therapy Suggest Revisions to the CLASS IIa Guidelines ‎ (← links)
• ST elevation myocardial infarction pre-hospital care ‎ (← links)
• The Living Guidelines: UA/NSTEMI Recommendations for Warfarin Therapy Suggest Revisions to the CLASS I Guidelines ‎ (← links)
• The Living Guidelines: UA/NSTEMI Recommendations for Warfarin Therapy Suggest Revisions to the CLASS IIb Guidelines ‎ (← links)
• ST elevation myocardial infarction secondary prevention ‎ (← links)
• ST elevation myocardial infarction aspirin therapy ‎ (← links)
• The Living Textbook of Cardiovascular Pharmacology ‎ (← links)
• ST elevation myocardial infarction thienopyridine therapy ‎ (← links)
• ST elevation myocardial infarction glycoprotein IIbIIIa inhibition ‎ (← links)
• ST elevation myocardial infarction coronary artery bypass grafting ‎ (← links)
• COMMIT-CCS 2 ‎ (← links)
• Jacko test ‎ (← links)
• Adenosine A1 receptor ‎ (← links)
• PCI in the patient in cardiogenic shock ‎ (← links)
• ST elevation myocardial infarction primary percutaneous coronary intervention ‎ (← links)
• Retroperitoneal hematoma ‎ (← links)
• Plasminogen activator ‎ (← links)
• TRITON-TIMI 38 stent analysis demonstrates that prasugrel is better than clopidogrel in reducing the incidence of early and late stent thrombosis ‎ (← links)
• Platelet monitoring can improve outcomes following PCI among clopidogrel resistant patients ‎ (← links)
• High recurrence rate of stent thrombosis after the first event: Results from the Dutch Stent Thrombosis Registry ‎ (← links)
• Reloading With Clopidogrel Improves Clinical Outcomes in Patients with Acute Coronary Syndromes: ARMYDA-RELOAD ‎ (← links)
• High dose tirofiban and clopidogrel are safe and effective in the ON-TIME-2 trial ‎ (← links)
• Vertebral artery dissection ‎ (← links)
• Research on Adverse Drug events And Reports ‎ (← links)
• Adenosine A3 receptor ‎ (← links)
• P2RY1 ‎ (← links)
• P2RY2 ‎ (← links)
• P2RY4 ‎ (← links)
• P2RY6 ‎ (← links)
• P2RY8 ‎ (← links)
• P2RY10 ‎ (← links)
• P2RY11 ‎ (← links)
• P2RY13 ‎ (← links)
• P2RY14 ‎ (← links)
• P2RX7 ‎ (← links)
• Nephrotoxic drugs ‎ (← links)
• Otamixaban ‎ (← links)